60 Degrees Pharmaceuticals (SXTP) Total Debt (2022 - 2025)
60 Degrees Pharmaceuticals (SXTP) posted quarterly Total Debt of $152775.0 for Q4 2025, down 2.0% year-over-year from $155891.0 in Q4 2024, and down 2.0% quarter-over-quarter from $155891.0 in Q4 2024.
60 Degrees Pharmaceuticals (SXTP) Total Debt (2022 - 2025) Analysis & Trends
60 Degrees Pharmaceuticals (SXTP) has reported Total Debt for 4 consecutive years, with $152775.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Total Debt fell 2.0% year-over-year to $152775.0; the TTM figure through Dec 2025 stood at $152775.0 (down 2.0% YoY), while the FY2025 annual figure was $152775.0, down 2.0% from the prior year.
- Total Debt slipped to $152775.0 in Q4 2025 per SXTP's latest filing, from $155891.0 in the prior quarter.
- Across five years, Total Debt topped out at $24.8 million in Q2 2023 and bottomed at $8772.0 in Q1 2024.
- Historically, Total Debt has averaged $4.7 million across 4 years, with a median of $155891.0 in 2024.
- Annual changes were most pronounced in 2023 — Total Debt slumped 99.75% — and 2024, when it soared 1042.06%.
- 60 Degrees Pharmaceuticals' Total Debt stood at $5.4 million in 2022, then plunged by 99.75% to $13650.0 in 2023, then jumped by 1042.06% to $155891.0 in 2024, then fell by 2.0% to $152775.0 in 2025.
- Business Quant data shows SXTP's Total Debt at $152775.0 in Q4 2025, $155891.0 in Q4 2024, and $8772.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.70 Bn | 131.85 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.74 Bn | 78.75 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 65.36 Bn | 60.18 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.15 Bn | 54.01 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.88 Bn | 28.57 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.14 Bn | 9.75 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.59 Bn | 26.43 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.48 Bn | - | 9.34 Bn |
| 10 | 60 Degrees Pharmaceuticals | 3.00 Mn | 1.98 Mn | 56,798.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 152,775.00 |
| Dec 31, 2024 | 155,891.00 |
| Mar 31, 2024 | 8,772.00 |
| Dec 31, 2023 | 13,650.00 |
| Sep 30, 2023 | 2.17 Mn |
| Jun 30, 2023 | 24.76 Mn |
| Dec 31, 2022 | 5.39 Mn |